91在线精品秘 一区二区,色诱一区二区,60熟妇高潮一区二区,美国av操逼

K107171PAnti-FGF1 Polyclonal Antibody

Anti-FGF1 Polyclonal Antibody 應(yīng)用WB 稀釋比例WB 1:5000-8000. 交叉反應(yīng)Human Mouse Rat

訪問次數(shù)：788    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107170PAnti-GA45G Polyclonal Antibody

Anti-GA45G Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:50-200. 交叉反應(yīng)Human Mouse Rat Cow

訪問次數(shù)：749    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107169PAnti-CST2 Polyclonal Antibody

Anti-CST2 Polyclonal Antibody 應(yīng) 用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:50-200. 交叉反應(yīng)Human

訪問次數(shù)：657    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107168PAnti-ID4 Polyclonal Antibody

Anti-ID4 Polyclonal Antibody 應(yīng) 用WB 稀釋比例WB 1:8000-12000. 交叉反應(yīng)Human Mouse Pig

訪問次數(shù)：690    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107167PAnti-FHIT Polyclonal Antibody

Anti-FHIT Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:100-300. 交叉反應(yīng)Human

訪問次數(shù)：719    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107166PAnti-TAC1 Polyclonal Antibody

Anti-TAC1 Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human Mouse Rat

訪問次數(shù)：748    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107165PAnti-STRA8 Polyclonal Antibody

Anti-STRA8 Polyclonal Antibody 應(yīng)用WB IHC 稀釋比例WB 1:5000-8000. IHC 1:100-300. 交叉反應(yīng)Human

訪問次數(shù)：710    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107164PAnti-FDCSP Polyclonal Antibody

Anti-FDCSP Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:25-100. 交叉反應(yīng)Human

訪問次數(shù)：726    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107163PAnti-H2AFX Polyclonal Antibody

Anti-H2AFX Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human

訪問次數(shù)：829    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14

K107162PAnti-HE4 Polyclonal Antibody

Anti-HE4 Polyclonal Antibody 應(yīng)用IHC 稀釋比例IHC 1:50-200. 交叉反應(yīng)Human

訪問次數(shù)：675    產(chǎn)品價格：面議    廠商性質(zhì)：生產(chǎn)廠家    更新日期：2022-08-14